TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32168423

Group type: EXPERIMENTAL
Intervention: sST2-guided treatment (known sST2 level)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Usual treatment (unknown sST2 level)
Number of subjects: 123
Study: 36197251

Group type: EXPERIMENTAL
Intervention: Psychological responses intervention (not specified in detail)
Number of subjects: 142
Study: 33718262

Group type: EXPERIMENTAL
Intervention: MLMA assay for identifying V. parahaemolyticus 57 K-serogroups
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: MLMA assay
Number of subjects: 595

Group type: COMPARATOR
Intervention: Traditional serotyping methods
Number of subjects: 595
Study: 32406009

Group type: EXPERIMENTAL
Intervention: TJ-28 (7500 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pyridoxine (60 mg/day)
Number of subjects: 22
Study: 34606954

Group type: EXPERIMENTAL
Intervention: TAAA repair
Number of subjects: 664

Group type: COMPARATOR
Intervention: Control population (without TAAAs)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Peripheral artery disease
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Congestive heart failure
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Urgent procedures
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Previous coronary revascularization
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: High-volume institutions (>60 TAAA repairs)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Older age, chronic kidney disease, congestive heart failure, urgent procedures
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Type of repair (endovascular vs open)
Number of subjects: 664
Study: 34014249

Group type: EXPERIMENTAL
Intervention: Anthracycline group (3 cycles of fluorouracil, epirubicin, and cyclophosphamide followed by 6 cycles of paclitaxel and carboplatin)
Number of subjects: 438

Group type: COMPARATOR
Intervention: Non-anthracycline group (9 cycles of paclitaxel and carboplatin)
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Anthracycline group
Number of subjects: 438

Group type: COMPARATOR
Intervention: Non-anthracycline group
Number of subjects: 438
Study: 32763872

Group type: EXPERIMENTAL
Intervention: Wrist-worn Fitbit Flex and app, weekly challenges, digital behavior change resources, email or text message alerts
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Text messages
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Weekly challenges
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Facebook videos
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Fitbit Flex
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Web-based delivery
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Facebook engagement
Number of subjects: 144
Study: 35329366

Group type: EXPERIMENTAL
Intervention: Experimental Outdoor (EO) intervention
Number of subjects: 106

Group type: COMPARATOR
Intervention: Traditional Indoor (TI) intervention
Number of subjects: 106
Study: 35942877

Group type: EXPERIMENTAL
Intervention: ICD implantation
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 1116
Study: 34652717

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Oblique Subcostal Transverse Abdominis Plane Block (TAPB)
Number of subjects: 62
Study: 35020056

Group type: EXPERIMENTAL
Intervention: Scheduled second look endoscopy (SLOGD)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 157
Study: 32744208

Group type: EXPERIMENTAL
Intervention: Monthly projections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quarterly projections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semiannual projections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual projections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: REACH-based probabilities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: USA life table probabilities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Half-a-cycle age correction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No half-a-cycle age correction
Number of subjects: 0
Study: 32052216

Group type: EXPERIMENTAL
Intervention: Goff septotomy
Number of subjects: 7984

Group type: COMPARATOR
Intervention: Control index ERCPs
Number of subjects: 7984

Group type: EXPERIMENTAL
Intervention: Double wire technique
Number of subjects: 7984

Group type: EXPERIMENTAL
Intervention: Needle knife precut
Number of subjects: 7984
Study: 32097622

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulations
Number of subjects: 0
Study: 34144370

Group type: EXPERIMENTAL
Intervention: Nomogram and risk matrix for predicting suicide risk
Number of subjects: 112372

Group type: EXPERIMENTAL
Intervention: Cox proportional hazard models
Number of subjects: 112372
Study: 32651587

Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (no EA)
Number of subjects: 110
Study: 35617826

Group type: EXPERIMENTAL
Intervention: AZ/BNT
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: BNT/BNT
Number of subjects: 254

Group type: COMPARATOR
Intervention: AZ/AZ
Number of subjects: 254
Study: 35753883

Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation (CSM) and exercise
Number of subjects: 176
Study: 36303476

Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated catheter
Number of subjects: 1594

Group type: COMPARATOR
Intervention: Standard catheter (control)
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Age < 1 month
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Age 1 month to < 1 year
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Age ≥ 65 years
Number of subjects: 1594
Study: 36064444

Group type: EXPERIMENTAL
Intervention: Trans-theoretical-based behavioral intervention package
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 360
Study: 32875913

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (TP‐MCT) in addition to the regular diet
Number of subjects: 0
Study: 32470703

Group type: EXPERIMENTAL
Intervention: Melatonin implant @ 18mg/50 kg B.Wt
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 12
Study: 33808180

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 19
Study: 34049869

Group type: EXPERIMENTAL
Intervention: Interactive web-based learning module on medication safety
Number of subjects: 16

Group type: COMPARATOR
Intervention: Five articles to read about medication safety (Control)
Number of subjects: 16
Study: 32333510

Group type: EXPERIMENTAL
Intervention: QR678 therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: PRP
Number of subjects: 50
Study: 35279105

Group type: EXPERIMENTAL
Intervention: Subcutaneous rhEPO (10,000 IU daily from 5 days preoperatively to 3 days postoperatively)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Subcutaneous normal saline (1 ml daily from 5 days preoperatively to 3 days preoperatively) followed by rhEPO (10,000 IU daily until 3 days postoperatively)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Subcutaneous normal saline (1 ml daily from 5 days preoperatively to 1 day preoperatively) followed by rhEPO (10,000 IU daily from the day of surgery to 3 days postoperatively)
Number of subjects: 180

Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Group C
Number of subjects: 180
Study: 34047297

Group type: EXPERIMENTAL
Intervention: TotalFill BC Sealer (TFBCS) soaked in simulated body fluid (SBF) for one day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TotalFill BC Sealer (TFBCS) soaked in simulated body fluid (SBF) for one week
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TotalFill BC Sealer (TFBCS) soaked in simulated body fluid (SBF) for two months
Number of subjects: 60

Group type: COMPARATOR
Intervention: MTA Fillapex (MTAFS) soaked in simulated body fluid (SBF) for one day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MTA Fillapex (MTAFS) soaked in simulated body fluid (SBF) for one week
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MTA Fillapex (MTAFS) soaked in simulated body fluid (SBF) for two months
Number of subjects: 60
Study: 32485328

Group type: EXPERIMENTAL
Intervention: argatroban plus r‐tPA
Number of subjects: 808

Group type: COMPARATOR
Intervention: r‐tPA alone
Number of subjects: 808
Study: 35018724

Group type: EXPERIMENTAL
Intervention: Granulation tissue preservation technique (GTPT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Double-flap approach with resection of the defect-filling granulation tissue (control group)
Number of subjects: 40
Study: 33720651

Group type: EXPERIMENTAL
Intervention: Sinupret (herbal medicine in oral drops)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard treatment supplemented with topical antibacterial drugs
Number of subjects: 107
Study: 36084520

Group type: EXPERIMENTAL
Intervention: Conditional financial incentive (CFI) - food voucher (~3.5 US dollars) for accepting home-based HIV test
Number of subjects: 24793

Group type: COMPARATOR
Intervention: Control group (no CFI)
Number of subjects: 24793
Study: 33325260

Group type: EXPERIMENTAL
Intervention: Training executive control (experimental group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Training processing speed (active control group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Experimental group (training executive control)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Motivation assessment during and after the intervention
Number of subjects: 44
Study: 35331534

Group type: EXPERIMENTAL
Intervention: Probiotic (8 × 10^9 CFU/day) plus 200 μg/day selenium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34231751

Group type: EXPERIMENTAL
Intervention: Neuromodulation intervention (not specified in detail)
Number of subjects: 31
Study: 32686502

Group type: EXPERIMENTAL
Intervention: Cemented acetabular cups
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Uncemented acetabular cups
Number of subjects: 26

Group type: COMPARATOR
Intervention: Referent healthy acetabulum
Number of subjects: 26
Study: 35844233

Group type: EXPERIMENTAL
Intervention: Combined MI training (CT and verum tDCS applied over the right dorsolateral prefrontal cortex)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cognitive MI training (CT and sham tDCS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (sham CT and sham tDCS)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups (BDs)
Number of subjects: 90
Study: 32616063

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg/day for three days, followed by 200 mg/day for 11 days
Number of subjects: 714

Group type: COMPARATOR
Intervention: Placebo (2 tablets for three days, followed by one tablet for 11 days)
Number of subjects: 714
Study: 36383882

Group type: EXPERIMENTAL
Intervention: 1200 mg oral NAC
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: rectal indomethacin 100 mg
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: 1200 mg oral NAC plus rectal indomethacin 100 mg
Number of subjects: 432

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 432
Study: 33742692

Group type: EXPERIMENTAL
Intervention: Nitrate-rich diet (200 mg of nitrate daily from lettuce juice beverage)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (placebo, void of nitrate)
Number of subjects: 37
Study: 32924550

Group type: EXPERIMENTAL
Intervention: Topical Costus sp. oil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical paraffin (placebo)
Number of subjects: 50
Study: 35405335

Group type: EXPERIMENTAL
Intervention: Experimental treatment (specifics not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (specifics not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group sequential enrichment design
Number of subjects: 0
Study: 33485836

Group type: EXPERIMENTAL
Intervention: 8-week combined ULA functional rehabilitation group (n=19) 3 days per week for 30 minutes
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional health care education protocol group (n=19) once a month for 8 weeks
Number of subjects: 38
Study: 34191588

Group type: EXPERIMENTAL
Intervention: HFD
Number of subjects: 6

Group type: COMPARATOR
Intervention: CH-CD
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HR-CD
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HR-HFD
Number of subjects: 6
Study: 34937223

Group type: EXPERIMENTAL
Intervention: Cold saline solution (0.9% NaCl)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Topical ophthalmic proparacaine
Number of subjects: 170
Study: 36112790

Group type: EXPERIMENTAL
Intervention: Acupressure applied to Li4, HT7, and Extra 1 points 30-60 minutes before CA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (CG) did not receive acupressure
Number of subjects: 100
Study: 34273676

Group type: EXPERIMENTAL
Intervention: Estradiol (2 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32143685

Group type: EXPERIMENTAL
Intervention: Intravenous golimumab 2 mg/kg (N=241; week 0, week 4, every 8 weeks)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo (N=239; week 0, week 4, week 12, week 20)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo→golimumab (after week 24)
Number of subjects: 480
Study: 34602038

Group type: EXPERIMENTAL
Intervention: Pilates protocol (8 weeks, 2 visits per week)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study: 34258264

Group type: EXPERIMENTAL
Intervention: Combined Oral Contraceptive (COC) pills (3 mg drospirenone and 0.03 mg ethinyl estradiol daily for 6 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No-treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (women without endometrioma)
Number of subjects: 36
Study: 34878526

Group type: EXPERIMENTAL
Intervention: Stratified care
Number of subjects: 951

Group type: COMPARATOR
Intervention: Stepped care
Number of subjects: 951
Study: 32991872

Group type: EXPERIMENTAL
Intervention: Rasch-rescaled UEFM
Number of subjects: 361

Group type: COMPARATOR
Intervention: Raw UEFM
Number of subjects: 361
Study: 32065946

Group type: EXPERIMENTAL
Intervention: Behavioral activation (BA) plus an exercise prescription
Number of subjects: 29

Group type: COMPARATOR
Intervention: Behavioral activation (BA) plus a stretching prescription
Number of subjects: 29
Study: 36096125

Group type: EXPERIMENTAL
Intervention: ePLND
Number of subjects: 272

Group type: COMPARATOR
Intervention: No PLND
Number of subjects: 272
Study: 33867065

Group type: EXPERIMENTAL
Intervention: Didactic lecture
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Jigsaw approach
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Fishbowl approach
Number of subjects: 130
Study: 32424621

Group type: EXPERIMENTAL
Intervention: Induced illusory control through manipulation of the base-rate of positive outcomes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34995124

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Transoral robotic surgery plus neck dissection (TORS + ND)
Number of subjects: 68
Study: 33119135

Group type: EXPERIMENTAL
Intervention: Food insulin index algorithm
Number of subjects: 15

Group type: COMPARATOR
Intervention: Carbohydrate counting
Number of subjects: 15
Study: 32483939

Group type: EXPERIMENTAL
Intervention: 2-octyl cyanoacrylate (Glue group)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-use of 2-octyl cyanoacrylate (non-Glue group)
Number of subjects: 26
Study: 35959593

Group type: EXPERIMENTAL
Intervention: Placebo (white capsule)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nocebo (yellow capsule)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no capsule)
Number of subjects: 19
Study: 33319950

Group type: EXPERIMENTAL
Intervention: ORi-based oxygen (group O)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional postoperative oxygen (group C)
Number of subjects: 50
Study: 32433165

Group type: EXPERIMENTAL
Intervention: Fixed low dose (FLD) of 259 MBq of I
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Fixed high dose (FHD) of 555 MBq of I
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Calculated dose (CD) to deliver 5.55 MBq/g of I
Number of subjects: 92
Study: 35028314

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine orally
Number of subjects: 80
Study: 34814839

Group type: EXPERIMENTAL
Intervention: Vibrotactile-enriched MBI
Number of subjects: 30

Group type: COMPARATOR
Intervention: Active MBI
Number of subjects: 30
Study: 36326308

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 60
Study: 32970104

Group type: EXPERIMENTAL
Intervention: Plinabulin 20 mg/m2 on day 1
Number of subjects: 55

Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg on day 2
Number of subjects: 55
Study: 34718548

Group type: EXPERIMENTAL
Intervention: Allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) in combination with standard treatment for frailty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allogeneic administration of umbilical cord-derived MSCs (UC-MSCs)
Number of subjects: 0
Study: 32394652

Group type: EXPERIMENTAL
Intervention: Kinematic-acupuncture therapy and rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional acupuncture and rehabilitation training
Number of subjects: 60
Study: 35617712

Group type: EXPERIMENTAL
Intervention: Family-based multimedia intervention (multimedia health talk)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (wait-list control)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Family-based multimedia intervention
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 320
Study: 34437550

Group type: EXPERIMENTAL
Intervention: Probability matching in a binary lottery game
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjects with experience in probability and statistics
Number of subjects: 0
Study: 35504312

Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy using a novel approach that combines computational modeling and deep learning.
Number of subjects: 0
Study: 34882200

Group type: EXPERIMENTAL
Intervention: 72 hours of cooling (group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 120 hours of cooling (group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Electrographic seizures during rewarming
Number of subjects: 120
Study: 34092635

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AT)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RT)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Combined exercise training (CT)
Number of subjects: 415
Study: 32658536

Group type: EXPERIMENTAL
Intervention: Reducing cigarettes per day (CPD)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Very low-nicotine-content (VLNC) cigarettes
Number of subjects: 68
Study: 32239448

Group type: EXPERIMENTAL
Intervention: Relaxation training (weekly sessions for 8 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Blood circulation training exercises (control group)
Number of subjects: 46
Study: 36040772

Group type: EXPERIMENTAL
Intervention: Psilocybin treatment (25 mg oral administration) with psychological support for 5-8 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psilocybin treatment
Number of subjects: 0
Study: 33751046

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (VAS)
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Vitamin A status assessment
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: MRDR assessment
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Serum carotenoids measurement
Number of subjects: 2831
Study: 34169678

Group type: EXPERIMENTAL
Intervention: RCTs with funding statements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RCTs over time (1979 to 2017)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical treatments
Number of subjects: 0
Study: 33410359

Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Informed Decision Making (IDM)
Number of subjects: 175
Study: 35368138

Group type: EXPERIMENTAL
Intervention: Continuous remote monitoring (CRM) of patients' vital signs
Number of subjects: 0
Study: 34101299

Group type: EXPERIMENTAL
Intervention: Keele STarT MSK Tool
Number of subjects: 2414
Study: 36320214

Group type: EXPERIMENTAL
Intervention: Standardized licorice syrup as an adjuvant treatment plus standard care (Syrup Group, N = 91)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Standard care alone (Standard Group, N = 104)
Number of subjects: 213
Study: 33942115

Group type: EXPERIMENTAL
Intervention: LGBT adults
Number of subjects: 1711
Study: 34501476

Group type: EXPERIMENTAL
Intervention: Single 30 min moderate-intensity aerobic exercise bout
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (sat and read for 30 min)
Number of subjects: 92
Study: 32442971

Group type: EXPERIMENTAL
Intervention: Thick, diffuse subarachnoid hemorrhage (SAH)
Number of subjects: 572

Group type: COMPARATOR
Intervention: Less hemorrhage burden (no thick, diffuse SAH)
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Thick, diffuse SAH
Number of subjects: 572
Study: 33401676

Group type: EXPERIMENTAL
Intervention: Sports smart bracelets and multi-component exercise program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 35234840

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 24081

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 24081

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 24081
Study: 32789561

Group type: EXPERIMENTAL
Intervention: Common mental disorders (anxiety, depression, PTSD)
Number of subjects: 1678

Group type: EXPERIMENTAL
Intervention: Socio-demographic, health and post-displacement variables
Number of subjects: 1678

Group type: EXPERIMENTAL
Intervention: Lifetime history of mental health treatment and problems accessing adequate healthcare
Number of subjects: 1678